ZY News and Press, Zymergen Inc. From 02/03/22

The Synthetic Biology sector underperformed the overall market in Q4 2021. Temporary supply chain disruptions drove the bulk of revenue headwinds. Convertible Debt Offering and Tax Loss Harvesting led to extreme Short Selling and are now behind the company. Early January 2022 ...

SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) today announced a new Automation business and updated portfolio, further refining the company’s focus on high-value solutions where its proprietary platform can provide distinct advantages. ...

SAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug discovery business based around their proprietary synthetic biology platform and what is believed to be the world’s largest metagenomics database, combining both size and...

EMERYVILLE, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”or the “Company”), today announced the company will be participating in the upcoming 40 th Annual J.P. Morgan Virtual Healthcare Conference. Zymergen’s management is s...

- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common stock Private Investment in Public Equity (“PIPE”) financing and from non-rede...

The S&P Materials Select Sector Index closed this trading week with a marginal +0.41% gain, while the Materials Select Sector SPDR ETF (NYSEARCA:XLB) was down -0.70%. London copper prices fell to their lowest in almost a month on Dec. 15, hitting $9,325 a ton, as cautious i...

Rather than achieving a growth inflection point, Zymergen recently abandoned their most mature products and rationalized their product portfolio. The CEO has been replaced and the co-founder and operations chief has stepped down, along with a hiring freeze and a large headcount reduct...

The S&P Materials Select Sector Index closed this trading week at -1.83%, one of the top losers in the index. The Materials Select Sector SPDR ETF (NYSEARCA:XLB) was also down -2.00%. In a recent analysis on all S&P sectors for 2022, Jefferies' global strategy team were Mode...

The revolutionary technology of synthetic biology is poised to make a profound impact on the way a vast array of products are manufactured, from lab-grown meat to cosmetics to biodegradable packaging. Like the internet revolution, companies that enable or effectively harness synthetic...

Rebounding from the 16% slide that they experienced last week, shares of Zymergen (NASDAQ: ZY) are soaring today as investors learn of an insider's significant acquisition of the company's stock. As of 10:34 a.m. ET, shares of the synthetic-biology company's stock are up 8.5%, h...